Sumitomo Mitsui Trust Group
MEDP icon

Sumitomo Mitsui Trust Group’s Medpace MEDP Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,872
Closed -$1.86M – 1108
2026
Q1 		$1.86M Sell
3,872
-1,055
-21% -$540K ﹤0.01% 796
2025
Q4 		$2.77M Buy
4,927
+3,627
+279% +$2.06M ﹤0.01% 771
2025
Q3 		$668K Buy
+1,300
New +$568K ﹤0.01% 897
2024
Q3 		– Sell
-1,756
Closed -$723K – 1086
2024
Q2 		$723K Hold
1,756
– – ﹤0.01% 931
2024
Q1 		$710K Sell
1,756
-300
-15% -$105K ﹤0.01% 991
2023
Q4 		$630K Buy
2,056
+856
+71% +$231K ﹤0.01% 1023
2023
Q3 		$291K Buy
+1,200
New +$307K ﹤0.01% 1089

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Sumitomo Mitsui Trust Group's MEDP Position: Q2 2026 in Review

Sumitomo Mitsui Trust Group sold out of Medpace (MEDP) in Q2 2026, closing a stake of 3,872 shares — an estimated $1.86M sold.

Sumitomo Mitsui Trust Group first reported a position in MEDP in Q3 2023 and held it in 7 quarters. The position peaked at $2.77M in Q4 2025. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Sumitomo Mitsui Trust Group reported no remaining Medpace position as of Q2 2026 after selling out during the quarter.
  • Sumitomo Mitsui Trust Group sold 3,872 Medpace shares in Q2 2026, an estimated $1.86M.
  • Sumitomo Mitsui Trust Group first reported a position in Medpace in Q3 2023 and held it in 7 quarters.
  • Sumitomo Mitsui Trust Group's Medpace position peaked at $2.77M in Q4 2025.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2026, filed 30 Jul 2026.